BUB
AZN icon

BBVA USA Bancshares’s AstraZeneca AZN Stock Holding History

BBVA USA Bancshares’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,085
Closed -$254K – 532
2017
Q1 		$254K Sell
4,085
-11,759
-74% -$685K 0.02% 494
2016
Q4 		$866K Sell
15,844
-12,513
-44% -$710K 0.06% 279
2016
Q3 		$1.86M Sell
28,357
-5,549
-16% -$363K 0.13% 155
2016
Q2 		$2.05M Sell
33,906
-1,480
-4% -$86K 0.15% 140
2016
Q1 		$1.99M Buy
35,386
+7,058
+25% +$424K 0.15% 154
2015
Q4 		$1.92M Buy
28,328
+14,680
+108% +$962K 0.14% 150
2015
Q3 		$868K Buy
13,648
+9,815
+256% +$646K 0.07% 231
2015
Q2 		$244K Buy
+3,833
New +$262K 0.01% 468

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return